NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
01/09/2024
Back to search
Official data from USPTO
BIOAGILYTIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
01/09/2024
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
02/24/2017
Registration date
09/26/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/07/2023
Last transaction
12/07/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2008-00-00
First use in commerce
2008-00-00
Drawing code
4
Owner type
16
Owner location
Durham, NC, US
Examiner
FAHRENKOPF, PAUL
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
BioAgilytix Labs, LLC
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Bioanalytical testing services; Bioanalytical laboratory servicesproject feasibility assessmentscustom method developmentmethod transfer/improvementmethod developmentvalidation and reportingbioanalysis to support clinical trialsquality assurance and bioanalytical report preparation; Research service and bioanalytical testing services in the fields of gene therapybiosimilarsantibody drug conjugatesimmune-oncology; Research and development into animal and plant biologymicrobiologycarrying out behavioralphysicalchemicalphysical chemicalbiochemicalbiologicalpharmacologicalphysiologicalmicrobiological analyses in the animal and plant fields; carrying out behavioralphysicalchemicalphysical chemicalbiochemicalbiologicalpharmacologicalphysiological or microbiological analyses in the chemicalbiotechnology and pharmaceutical industries; carrying out genetic analysis in the animal or plant fields; carrying out genetic analyses in the chemicalbiotechnology and pharmaceutical industries; Consulting services in the fields of analytical chemistrypharmacologypharmacokineticsdrug deliverydrug metabolismdrug toxicologyveterinary sciencecontract research servicespreclinical and clinical trialsproduct development and evaluationlaboratory support
Publications
History of USPTO decisions and trademark events.
16 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/07/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/07/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/05/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/12/2023
E815
TEAS SECTION 8 & 15 RECEIVED
10/13/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/26/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2017
PUBO
PUBLISHED FOR OPPOSITION
07/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2017
DOCK
ASSIGNED TO EXAMINER
05/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2017
NWAP
NEW APPLICATION ENTERED
02/28/2017
Continuous trademark protection
Get notified about every new filing that threatens BIOAGILYTIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.